Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Ended earlyNCT01774851What this trial is testingMM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachWho this might be right forHER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)UnknownNCT05188209What this trial is testingEvaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.Who this might be right forAdvanced or Metastatic Gastric CancerAdvanced or Metastatic Gastroesophageal Junction Carcinoma Shanghai Miracogen Inc. 60
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Looking for participantsNCT05365581What this trial is testingASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerWho this might be right forGastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 398
Early research (Phase 1)Looking for participantsNCT05107674What this trial is testingNX-1607 in Adults With Advanced MalignanciesWho this might be right forOvarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Looking for participantsNCT06415669What this trial is testingPaclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric/Gastroesophageal Junction Adenocarcinoma The First Affiliated Hospital of Xiamen University 30
Not applicableAvailableNCT06048081What this trial is testingEarly Access Program for ZolbetuximabWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more Astellas Pharma Global Development, Inc.
Not applicableLooking for participantsNCT06902545What this trial is testingObserve the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06730373What this trial is testingFirst-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)Who this might be right forHER2-positive Gastric CancerMetastatic Gastric CancerUnresectable Gastric Carcinoma Qilu Hospital of Shandong University 110
Not applicableStudy completedNCT05892926What this trial is testingHER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in RussiaWho this might be right forAdenocarcinoma AstraZeneca 204
Testing effectiveness (Phase 2)Looking for participantsNCT06251973What this trial is testingAgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerWho this might be right forMetastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more Memorial Sloan Kettering Cancer Center 37
Early research (Phase 1)Active Not RecruitingNCT06714617What this trial is testingEvaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsWho this might be right forBreast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more SystImmune Inc. 120
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Early research (Phase 1)Looking for participantsNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT07385703What this trial is testingClinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.Who this might be right forAdenocarcinoma Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 752
Large-scale testing (Phase 3)Study completedNCT03933449What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyWho this might be right forEsophageal CarcinomaEsophagogastric Junction Carcinoma Merck Sharp & Dohme LLC 123
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 60